{"transactions":[{"id":1600382,"issuer":{"id":92707,"kind":"organization","name":"Cyteir Therapeutics, Inc.","symbol":"CYT"},"owners":[{"id":90124,"kind":"person","name":"Gaiero David G","position":1,"cik":"0001799784","reported_name":"Gaiero David G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-05T18:11:17.000Z","date":"2024-03-04","kind":"exercise","planned":false,"acquired":false,"shares":2373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 1/48th of the underlying shares on each monthly anniversary of the vesting commencement date until the option is fully vested, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date."}],"balance_after":83052,"derivative":{"exercise_price":1.69,"expiration_date":"2033-02-03","underlying":"Common Stock","underlying_shares":2373},"source":{"system":"sec-edgar","filing":"0001209191-24-004439","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1799784/000120919124004439/doc4.xml","form_type":"4"}},{"id":1600381,"issuer":{"id":92707,"kind":"organization","name":"Cyteir Therapeutics, Inc.","symbol":"CYT"},"owners":[{"id":90124,"kind":"person","name":"Gaiero David G","position":1,"cik":"0001799784","reported_name":"Gaiero David G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-05T18:11:17.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":false,"shares":4746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 1/48th of the underlying shares on each monthly anniversary of the vesting commencement date until the option is fully vested, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date."}],"balance_after":85425,"derivative":{"exercise_price":1.69,"expiration_date":"2033-02-03","underlying":"Common Stock","underlying_shares":4746},"source":{"system":"sec-edgar","filing":"0001209191-24-004439","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1799784/000120919124004439/doc4.xml","form_type":"4"}},{"id":1600380,"issuer":{"id":92707,"kind":"organization","name":"Cyteir Therapeutics, Inc.","symbol":"CYT"},"owners":[{"id":90124,"kind":"person","name":"Gaiero David G","position":1,"cik":"0001799784","reported_name":"Gaiero David G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-05T18:11:17.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":false,"shares":3239,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested as to 25% of the underlying shares of common stock on December 7, 2021, the first anniversary of the vesting commencement date, and vests as to 1/48th of the underlying shares thereafter on each subsequent monthly anniversary of the vesting commencement date until the option is fully vested, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date."}],"balance_after":16196,"derivative":{"exercise_price":1.68,"expiration_date":"2030-12-10","underlying":"Common Stock","underlying_shares":3239},"source":{"system":"sec-edgar","filing":"0001209191-24-004439","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799784/000120919124004439/doc4.xml","form_type":"4"}},{"id":1600379,"issuer":{"id":92707,"kind":"organization","name":"Cyteir Therapeutics, Inc.","symbol":"CYT"},"owners":[{"id":90124,"kind":"person","name":"Gaiero David G","position":1,"cik":"0001799784","reported_name":"Gaiero David G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-05T18:11:17.000Z","date":"2024-03-04","kind":"exercise","planned":false,"acquired":true,"shares":2373,"price":1.69,"value":4010.37,"ownership":{"direct":true},"balance_after":102391,"source":{"system":"sec-edgar","filing":"0001209191-24-004439","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799784/000120919124004439/doc4.xml","form_type":"4"}},{"id":1600378,"issuer":{"id":92707,"kind":"organization","name":"Cyteir Therapeutics, Inc.","symbol":"CYT"},"owners":[{"id":90124,"kind":"person","name":"Gaiero David G","position":1,"cik":"0001799784","reported_name":"Gaiero David G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-05T18:11:17.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":true,"shares":4746,"price":1.69,"value":8020.74,"ownership":{"direct":true},"balance_after":100018,"source":{"system":"sec-edgar","filing":"0001209191-24-004439","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799784/000120919124004439/doc4.xml","form_type":"4"}},{"id":1600377,"issuer":{"id":92707,"kind":"organization","name":"Cyteir Therapeutics, Inc.","symbol":"CYT"},"owners":[{"id":90124,"kind":"person","name":"Gaiero David G","position":1,"cik":"0001799784","reported_name":"Gaiero David G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-05T18:11:17.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":true,"shares":3239,"price":1.68,"value":5441.52,"ownership":{"direct":true},"balance_after":95272,"source":{"system":"sec-edgar","filing":"0001209191-24-004439","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799784/000120919124004439/doc4.xml","form_type":"4"}},{"id":1711713,"issuer":{"id":92707,"kind":"organization","name":"Cyteir Therapeutics, Inc.","symbol":"CYT"},"owners":[{"id":90124,"kind":"person","name":"Gaiero David G","position":1,"cik":"0001799784","reported_name":"Gaiero David G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-14T16:00:15.000Z","date":"2023-12-11","kind":"exercise","planned":false,"acquired":false,"shares":2373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 1/48th of the underlying shares thereafter on each subsequent monthly anniversary of the vesting commencement date until the option is fully vested, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date."}],"balance_after":90171,"derivative":{"exercise_price":1.69,"expiration_date":"2033-02-03","underlying":"Common Stock","underlying_shares":2373},"source":{"system":"sec-edgar","filing":"0001209191-23-058610","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799784/000120919123058610/doc4.xml","form_type":"4"}},{"id":1711712,"issuer":{"id":92707,"kind":"organization","name":"Cyteir Therapeutics, Inc.","symbol":"CYT"},"owners":[{"id":90124,"kind":"person","name":"Gaiero David G","position":1,"cik":"0001799784","reported_name":"Gaiero David G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-14T16:00:15.000Z","date":"2023-12-11","kind":"exercise","planned":false,"acquired":false,"shares":1620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested as to 25% of the underlying shares of common stock on December 7, 2021, the first anniversary of the vesting commencement date, and vests as to 1/48th of the underlying shares thereafter on each subsequent monthly anniversary of the vesting commencement date until the option is fully vested, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date."}],"balance_after":19435,"derivative":{"exercise_price":1.68,"expiration_date":"2030-12-10","underlying":"Common Stock","underlying_shares":1620},"source":{"system":"sec-edgar","filing":"0001209191-23-058610","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799784/000120919123058610/doc4.xml","form_type":"4"}},{"id":1711711,"issuer":{"id":92707,"kind":"organization","name":"Cyteir Therapeutics, Inc.","symbol":"CYT"},"owners":[{"id":90124,"kind":"person","name":"Gaiero David G","position":1,"cik":"0001799784","reported_name":"Gaiero David G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-14T16:00:15.000Z","date":"2023-12-11","kind":"exercise","planned":false,"acquired":true,"shares":2373,"price":1.69,"value":4010.37,"ownership":{"direct":true},"balance_after":92033,"source":{"system":"sec-edgar","filing":"0001209191-23-058610","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799784/000120919123058610/doc4.xml","form_type":"4"}},{"id":1711710,"issuer":{"id":92707,"kind":"organization","name":"Cyteir Therapeutics, Inc.","symbol":"CYT"},"owners":[{"id":90124,"kind":"person","name":"Gaiero David G","position":1,"cik":"0001799784","reported_name":"Gaiero David G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-14T16:00:15.000Z","date":"2023-12-11","kind":"exercise","planned":false,"acquired":true,"shares":1620,"price":1.68,"value":2721.6,"ownership":{"direct":true},"balance_after":89660,"source":{"system":"sec-edgar","filing":"0001209191-23-058610","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799784/000120919123058610/doc4.xml","form_type":"4"}},{"id":1731925,"issuer":{"id":92707,"kind":"organization","name":"Cyteir Therapeutics, Inc.","symbol":"CYT"},"owners":[{"id":90124,"kind":"person","name":"Gaiero David G","position":1,"cik":"0001799784","reported_name":"Gaiero David G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-22T13:47:57.000Z","date":"2023-11-20","kind":"exercise","planned":false,"acquired":false,"shares":21356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests as to 1/48th of the underlying shares thereafter on each subsequent monthly anniversary of the vesting commencement date until the option is fully vested, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date."}],"balance_after":92544,"derivative":{"exercise_price":1.69,"expiration_date":"2033-02-03","underlying":"Common Stock","underlying_shares":21356},"source":{"system":"sec-edgar","filing":"0001209191-23-056425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799784/000120919123056425/doc4.xml","form_type":"4"}},{"id":1731924,"issuer":{"id":92707,"kind":"organization","name":"Cyteir Therapeutics, Inc.","symbol":"CYT"},"owners":[{"id":90124,"kind":"person","name":"Gaiero David G","position":1,"cik":"0001799784","reported_name":"Gaiero David G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-22T13:47:57.000Z","date":"2023-11-20","kind":"exercise","planned":false,"acquired":false,"shares":52584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested as to 25% of the underlying shares of common stock on December 7, 2021, the first anniversary of the vesting commencement date, and vests as to 1/48th of the underlying shares thereafter on each subsequent monthly anniversary of the vesting commencement date until the option is fully vested, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date."}],"balance_after":21055,"derivative":{"exercise_price":1.68,"expiration_date":"2030-12-10","underlying":"Common Stock","underlying_shares":52584},"source":{"system":"sec-edgar","filing":"0001209191-23-056425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799784/000120919123056425/doc4.xml","form_type":"4"}},{"id":1731923,"issuer":{"id":92707,"kind":"organization","name":"Cyteir Therapeutics, Inc.","symbol":"CYT"},"owners":[{"id":90124,"kind":"person","name":"Gaiero David G","position":1,"cik":"0001799784","reported_name":"Gaiero David G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-22T13:47:57.000Z","date":"2023-11-20","kind":"exercise","planned":false,"acquired":true,"shares":21356,"price":1.69,"value":36091.64,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 5,000 shares of the Company's common stock pursuant to the Cyteir Therapeutics, Inc. Employee Stock Purchase Program (\"ESPP\"). In accordance with the ESPP, these shares were purchased based on 85% of the closing stock price on January 17, 2023."}],"balance_after":88040,"source":{"system":"sec-edgar","filing":"0001209191-23-056425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799784/000120919123056425/doc4.xml","form_type":"4"}},{"id":1731922,"issuer":{"id":92707,"kind":"organization","name":"Cyteir Therapeutics, Inc.","symbol":"CYT"},"owners":[{"id":90124,"kind":"person","name":"Gaiero David G","position":1,"cik":"0001799784","reported_name":"Gaiero David G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-22T13:47:57.000Z","date":"2023-11-20","kind":"exercise","planned":false,"acquired":true,"shares":52584,"price":1.68,"value":88341.12,"ownership":{"direct":true},"balance_after":66684,"source":{"system":"sec-edgar","filing":"0001209191-23-056425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799784/000120919123056425/doc4.xml","form_type":"4"}},{"id":2029596,"issuer":{"id":92707,"kind":"organization","name":"Cyteir Therapeutics, Inc.","symbol":"CYT"},"owners":[{"id":90124,"kind":"person","name":"Gaiero David G","position":1,"cik":"0001799784","reported_name":"Gaiero David G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-07T16:41:44.000Z","date":"2023-02-03","kind":"grant","acquired":true,"shares":113900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock underlying this stock option award vest as to 2.083% in 48 equal monthly installments after the grant date, subject to the Reporting Person's continued employment with the Company through the applicable vesting date."}],"balance_after":113900,"derivative":{"exercise_price":1.69,"expiration_date":"2033-02-03","underlying":"Common Stock","underlying_shares":113900},"source":{"system":"sec-edgar","filing":"0001209191-23-007536","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799784/000120919123007536/doc4.xml","form_type":"4"}},{"id":2029595,"issuer":{"id":92707,"kind":"organization","name":"Cyteir Therapeutics, Inc.","symbol":"CYT"},"owners":[{"id":90124,"kind":"person","name":"Gaiero David G","position":1,"cik":"0001799784","reported_name":"Gaiero David G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-07T16:41:44.000Z","date":"2023-01-13","kind":"grant","acquired":true,"shares":5000,"price":1.49,"value":7450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of the Company's common stock pursuant to the Cyteir Therapeutics, Inc. Employee Stock Purchase Program (\"ESPP\"), for the ESPP purchase period of July 15, 2022 through January 13, 2023. This transaction is also exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased based on 85% of the closing stock price January 13, 2023, the last trading day of the purchase period."}],"balance_after":9100,"source":{"system":"sec-edgar","filing":"0001209191-23-007536","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799784/000120919123007536/doc4.xml","form_type":"4"}},{"id":2029598,"issuer":{"id":92707,"kind":"organization","name":"Cyteir Therapeutics, Inc.","symbol":"CYT"},"owners":[{"id":90124,"kind":"person","name":"Gaiero David G","position":1,"cik":"0001799784","reported_name":"Gaiero David G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-07T16:38:17.000Z","date":"2021-12-20","kind":"exercise","acquired":false,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Due to rounding in connection with the Issuer's reverse stock split during its initial public offering, the exercise price for this option was immaterially incorrect as reported on the Reporting Person's Form 3 filing on June 17, 2021, and has been corrected in this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested as to 25% of the underlying shares of common stock on December 7, 2021, the first anniversary of the vesting commencement date, and vests 1/48th of the underlying shares thereafter on each subsequent monthly anniversary of the vesting commencement date until the option is fully vested, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date."}],"balance_after":73639,"derivative":{"exercise_price":1.68,"expiration_date":"2030-12-10","underlying":"Common Stock","underlying_shares":4100},"source":{"system":"sec-edgar","filing":"0001209191-23-007528","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799784/000120919123007528/doc4.xml","form_type":"4"}},{"id":2029597,"issuer":{"id":92707,"kind":"organization","name":"Cyteir Therapeutics, Inc.","symbol":"CYT"},"owners":[{"id":90124,"kind":"person","name":"Gaiero David G","position":1,"cik":"0001799784","reported_name":"Gaiero David G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-07T16:38:17.000Z","date":"2021-12-20","kind":"exercise","acquired":true,"shares":4100,"price":1.68,"value":6888.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Due to rounding in connection with the Issuer's reverse stock split during its initial public offering, the exercise price for this option was immaterially incorrect as reported on the Reporting Person's Form 3 filing on June 17, 2021, and has been corrected in this Form 4."}],"balance_after":4100,"source":{"system":"sec-edgar","filing":"0001209191-23-007528","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799784/000120919123007528/doc4.xml","form_type":"4"}},{"id":2376343,"issuer":{"id":92707,"kind":"organization","name":"Cyteir Therapeutics, Inc.","symbol":"CYT"},"owners":[{"id":90124,"kind":"person","name":"Gaiero David G","position":1,"cik":"0001799784","reported_name":"Gaiero David G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-24T16:54:13.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this stock option award vest as to 2.083% in 48 equal monthly installments, subject to the Reporting Person's continued employment with the Company through the applicable vesting date."}],"balance_after":23000,"derivative":{"exercise_price":5.96,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0000899243-22-007631","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799784/000089924322007631/doc4.xml","form_type":"4"}},{"id":3225675,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":90124,"kind":"person","name":"Gaiero David G","position":1,"cik":"0001799784","reported_name":"Gaiero David G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Share Option (right to buy)","published_at":"2020-03-05T20:48:48.000Z","date":"2020-03-03","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 50% of the shares on February 1, 2021 and 50% on February 1, 2022."}],"balance_after":18000,"derivative":{"exercise_price":8.17,"expiration_date":"2030-03-03","underlying":"Ordinary Shares","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0000899243-20-007284","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799784/000089924320007284/doc4.xml","form_type":"4"}},{"id":3289860,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":90124,"kind":"person","name":"Gaiero David G","position":1,"cik":"0001799784","reported_name":"Gaiero David G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Ordinary Shares","published_at":"2020-02-05T18:16:41.000Z","date":"2020-02-03","kind":"sale","acquired":false,"shares":651,"price":7,"value":4557.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 3, 2020, the reporting person sold 651 ordinary shares solely to cover taxes associated with the vesting of restricted share units on February 1, 2020. These sales were made pursuant to a 10b5-1 Trading Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $7.00 to $7.049 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":6392,"source":{"system":"sec-edgar","filing":"0000899243-20-003379","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799784/000089924320003379/doc4.xml","form_type":"4"}}]}